H S Mueller - JoVE Visualize

Showing results (11-20 of 36) with videos related to

Pageof 4

Sort By:

Circulation Research|April 1, 1990

Impaired prostaglandin E1/I2 receptor activity of human blood platelets in acute ischemic heart diseaseN N Kahn, H S Mueller, A K Sinha

Radiology|July 1, 1980

Sequential thallium-201 myocardial scintigraphy after acute infarction in man: comparison to creatine kinase-MB release patternJ W Fletcher, H S Mueller, P S Rao

Journal of the American College of Cardiology|September 1, 1987

Thrombolysis in myocardial infarction (TIMI): comparative studies of coronary reperfusion and systemic fibrinogenolysis with two forms of recombinant tissue-type plasminogen activatorH S Mueller, A K Rao, S A Forman

The Medical Clinics of North America|January 1, 1988

Thrombolytic therapy in acute myocardial infarction: Part IH S Mueller, R Roberts, S L Teichman, et al.

The Medical Clinics of North America|March 1, 1989

Thrombolytic therapy in acute myocardial infarction: Part II--rt-PAH S Mueller, R Roberts, S L Teichman, et al.

Pharmacotherapy|September 1, 1981

Nifedipine in the treatment of cardiovascular diseaseH S Mueller, E M Antman, J A Ferst, et al.

American Heart Journal|June 1, 1985

Sub-aggregatory doses of catecholamines prevent prostacyclin-induced inhibition of platelet aggregationP M Buttrick, C A Forscher, I I Sussman, et al.

Biochemical and Biophysical Research Communications|January 15, 1988

Specificity of oxygen radical scavengers and assessment of free radical scavenger efficiency using luminol enhanced chemiluminescenceP S Rao, J M Luber, J Milinowicz, et al.

Cardiovascular Research|March 1, 1985

Evaluation of a rat model for assessing interventions to salvage ischaemic myocardium: effects of ibuprofen and verapamilR G Evans, J E Val-Mejias, J Kulevich, et al.

Journal of the American College of Cardiology|October 1, 1995

Prognostic significance of nonfatal reinfarction during 3-year follow-up: results of the Thrombolysis in Myocardial Infarction (TIMI) phase II clinical trial. The TIMI InvestigatorsH S Mueller, S A Forman, M A Menegus, et al.

Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:

Pageof 4

Circulation Research|April 1, 1990

Impaired prostaglandin E1/I2 receptor activity of human blood platelets in acute ischemic heart diseaseN N Kahn, H S Mueller, A K Sinha

Radiology|July 1, 1980

Sequential thallium-201 myocardial scintigraphy after acute infarction in man: comparison to creatine kinase-MB release patternJ W Fletcher, H S Mueller, P S Rao

Journal of the American College of Cardiology|September 1, 1987

Thrombolysis in myocardial infarction (TIMI): comparative studies of coronary reperfusion and systemic fibrinogenolysis with two forms of recombinant tissue-type plasminogen activatorH S Mueller, A K Rao, S A Forman

The Medical Clinics of North America|January 1, 1988

Thrombolytic therapy in acute myocardial infarction: Part IH S Mueller, R Roberts, S L Teichman, et al.

The Medical Clinics of North America|March 1, 1989

Thrombolytic therapy in acute myocardial infarction: Part II--rt-PAH S Mueller, R Roberts, S L Teichman, et al.

Pharmacotherapy|September 1, 1981

Nifedipine in the treatment of cardiovascular diseaseH S Mueller, E M Antman, J A Ferst, et al.

American Heart Journal|June 1, 1985

Sub-aggregatory doses of catecholamines prevent prostacyclin-induced inhibition of platelet aggregationP M Buttrick, C A Forscher, I I Sussman, et al.

Biochemical and Biophysical Research Communications|January 15, 1988

Specificity of oxygen radical scavengers and assessment of free radical scavenger efficiency using luminol enhanced chemiluminescenceP S Rao, J M Luber, J Milinowicz, et al.

Cardiovascular Research|March 1, 1985

Evaluation of a rat model for assessing interventions to salvage ischaemic myocardium: effects of ibuprofen and verapamilR G Evans, J E Val-Mejias, J Kulevich, et al.

Journal of the American College of Cardiology|October 1, 1995

Prognostic significance of nonfatal reinfarction during 3-year follow-up: results of the Thrombolysis in Myocardial Infarction (TIMI) phase II clinical trial. The TIMI InvestigatorsH S Mueller, S A Forman, M A Menegus, et al.

Pageof 4